David Schlett joins Prime Therapeutics as Chief Financial Officer

Schlett is an experienced finance executive with more than 25 years of business, leadership experience

January 9, 2020

EAGAN, Minn. – Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 28 million members nationally, has welcomed David Schlett as its new chief financial officer (CFO). Schlett is an experienced finance executive with more than 25 years of business and leadership experience. As CFO, he will oversee Prime’s corporate finance area, including pricing and underwriting, treasury and internal audit, real estate, financial planning and controller functions.

Dave SchlettSchlett has deep roots in health care and the pharmacy industry. He held finance leadership positions at Medco and served as Express Scripts’ senior vice president of finance. Most recently he worked for Cambridge Advisory Group, and operated his own independent consultancy, providing financial, pharmacy and health care advisory services.

“Dave is a perfect fit for Prime,” said Prime’s President and CEO Ken Paulus. “As we searched for a new CFO, we were fortunate to have this well-respected, highly sought-after finance professional serve as an advisor to us this past year. Dave exhibited the depth and breadth of experience that Prime needs in this crucial position. We are delighted to have him join our team during this transformative time in health care.”

“I’m delighted to join Prime at this point in the company’s evolution,” said David Schlett, Prime’s new CFO. “The industry continues to evolve and Prime is uniquely positioned to create the PBM of the future, providing total drug management leading to better patient outcomes and lower plan cost.”

Schlett earned both a Master of Business Administration in Finance and a Bachelor of Arts in Business Administration and Accounting from Rutgers University in New Brunswick, NJ. He also is a certified public accountant (CPA).

Related news

Press releases

October 19, 2021

Going beyond the first fill: Prime Therapeutics, NCODA collaboration enables improved patient outcomes through new oncology pharmacy accreditation

EAGAN, Minn. and CAZENOVIA, NY –  Prime Therapeutics (Prime), a leading pharmacy benefit…

Press releases

October 18, 2021

Cancer patients, caregivers benefit with integrated clinic-to-pharmacy care through Prime Therapeutics’ IntegratedRx™ – Oncology

EAGAN, Minn. – Prime Therapeutics, a leading pharmacy benefit manager (PBM) serving more…

Press releases

October 14, 2021

In first of its kind study, Prime Therapeutics explores paroxysmal nocturnal hemoglobinuria (PNH) C5 inhibitor treatment rates

EAGAN, Minn. – Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) used its…